Neuron23 is a series c plus startup based in United States. 3 investors tracked on Brouky Intelligence. Data sourced from Brouky Intelligence.
About
The startup, which leverages AI technology to develop precision medicine for immunological diseases, has raised $213.5M in funding to date.
Stage
series-c-plus
Investors
3
See full investor history, risk signals & comparable companies
Brouky tracks 15,000+ startups with funding rounds, risk analysis, and AI-powered investor matching.
Subscribe to Brouky